FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3195217596> ?p ?o ?g. }

• W3195217596 endingPage "178" @default.
• W3195217596 startingPage "166" @default.
• W3195217596 abstract "Patients with cancer are treated with chemotherapeutics that cause adverse effects, including erectile dysfunction (ED).We investigated erectile function in rats after the administration of anticancer agents based on data retrieved through mining of the US Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) database.The statistical signal strength for the association between anticancer drugs and ED was calculated using the reporting odds ratio (ROR). A drug-event combination was detected when the lower limit of the 95% confidence interval (CI) of the ROR exceeded 1.00. Rats were administered anticancer agents detected in the FDA AERS analysis. Erectile function was assessed using intracavernous pressure (ICP) and mean arterial pressure (MAP) analysis after electrical stimulation of the cavernous nerve. Statistical significance was determined using Welch's t-test or two-way ANOVA.Melphalan (L-PAM; ROR = 4.72, 95% CI = 2.78-8.00), vincristine (VCR; ROR = 2.47, 95% CI = 1.54-3.97), docetaxel (DTX; ROR = 2.25, 95% CI = 1.28-3.95), methotrexate (MTX; ROR = 1.96, 95% CI = 1.39-2.75), and doxorubicin (DOX; ROR = 1.82, 95% CI = 1.07-3.19) enhanced ED risk. L-PAM and MTX decreased the ICP/MAP ratio 1 week after administration. VCR and DOX decreased erectile function 4 weeks after administration. DTX decreased erectile function at all assessed time points.Certain anticancer agents should be considered risk factors for ED. Our results provide possible treatment strategies for maintaining erectile function in cancer survivors, including careful erectile function monitoring after treatment." @default.
• W3195217596 created "2021-08-30" @default.
• W3195217596 creator A5013235649 @default.
• W3195217596 creator A5016842741 @default.
• W3195217596 creator A5023948696 @default.
• W3195217596 creator A5028784529 @default.
• W3195217596 creator A5055762467 @default.
• W3195217596 creator A5066667992 @default.
• W3195217596 creator A5069047580 @default.
• W3195217596 creator A5075451513 @default.
• W3195217596 creator A5079084954 @default.
• W3195217596 date "2021-08-31" @default.
• W3195217596 modified "2023-10-16" @default.
• W3195217596 title "Influence of anticancer agents on sexual function: An in vivo study based on the US FDA Adverse Event Reporting System" @default.
• W3195217596 cites W1546556834 @default.
• W3195217596 cites W1693670319 @default.
• W3195217596 cites W1742120220 @default.
• W3195217596 cites W1802197986 @default.
• W3195217596 cites W1970060526 @default.
• W3195217596 cites W1985366927 @default.
• W3195217596 cites W1988100739 @default.
• W3195217596 cites W1990684695 @default.
• W3195217596 cites W2046581108 @default.
• W3195217596 cites W2064716383 @default.
• W3195217596 cites W2100830321 @default.
• W3195217596 cites W2112357770 @default.
• W3195217596 cites W2115147276 @default.
• W3195217596 cites W2116532074 @default.
• W3195217596 cites W2121960517 @default.
• W3195217596 cites W2141414884 @default.
• W3195217596 cites W2142831070 @default.
• W3195217596 cites W2153972688 @default.
• W3195217596 cites W2162661850 @default.
• W3195217596 cites W2171360288 @default.
• W3195217596 cites W2225428464 @default.
• W3195217596 cites W2283875305 @default.
• W3195217596 cites W2312561724 @default.
• W3195217596 cites W2418856366 @default.
• W3195217596 cites W2531803235 @default.
• W3195217596 cites W2559861310 @default.
• W3195217596 cites W2591717879 @default.
• W3195217596 cites W2616553828 @default.
• W3195217596 cites W2753767037 @default.
• W3195217596 cites W2758825568 @default.
• W3195217596 cites W2767446695 @default.
• W3195217596 cites W2772364909 @default.
• W3195217596 cites W2799399088 @default.
• W3195217596 cites W2800509438 @default.
• W3195217596 cites W2886155385 @default.
• W3195217596 cites W3036156178 @default.
• W3195217596 cites W3083602964 @default.
• W3195217596 cites W3195217596 @default.
• W3195217596 doi "https://doi.org/10.1111/andr.13094" @default.
• W3195217596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34390622" @default.
• W3195217596 hasPublicationYear "2021" @default.
• W3195217596 type Work @default.
• W3195217596 sameAs 3195217596 @default.
• W3195217596 citedByCount "6" @default.
• W3195217596 countsByYear W31952175962021 @default.
• W3195217596 countsByYear W31952175962022 @default.
• W3195217596 countsByYear W31952175962023 @default.
• W3195217596 crossrefType "journal-article" @default.
• W3195217596 hasAuthorship W3195217596A5013235649 @default.
• W3195217596 hasAuthorship W3195217596A5016842741 @default.
• W3195217596 hasAuthorship W3195217596A5023948696 @default.
• W3195217596 hasAuthorship W3195217596A5028784529 @default.
• W3195217596 hasAuthorship W3195217596A5055762467 @default.
• W3195217596 hasAuthorship W3195217596A5066667992 @default.
• W3195217596 hasAuthorship W3195217596A5069047580 @default.
• W3195217596 hasAuthorship W3195217596A5075451513 @default.
• W3195217596 hasAuthorship W3195217596A5079084954 @default.
• W3195217596 hasBestOaLocation W31952175961 @default.
• W3195217596 hasConcept C121608353 @default.
• W3195217596 hasConcept C126322002 @default.
• W3195217596 hasConcept C126894567 @default.
• W3195217596 hasConcept C143998085 @default.
• W3195217596 hasConcept C156957248 @default.
• W3195217596 hasConcept C197934379 @default.
• W3195217596 hasConcept C2777105317 @default.
• W3195217596 hasConcept C2779929075 @default.
• W3195217596 hasConcept C2781190966 @default.
• W3195217596 hasConcept C44249647 @default.
• W3195217596 hasConcept C65409693 @default.
• W3195217596 hasConcept C71924100 @default.
• W3195217596 hasConcept C98274493 @default.
• W3195217596 hasConceptScore W3195217596C121608353 @default.
• W3195217596 hasConceptScore W3195217596C126322002 @default.
• W3195217596 hasConceptScore W3195217596C126894567 @default.
• W3195217596 hasConceptScore W3195217596C143998085 @default.
• W3195217596 hasConceptScore W3195217596C156957248 @default.
• W3195217596 hasConceptScore W3195217596C197934379 @default.
• W3195217596 hasConceptScore W3195217596C2777105317 @default.
• W3195217596 hasConceptScore W3195217596C2779929075 @default.
• W3195217596 hasConceptScore W3195217596C2781190966 @default.
• W3195217596 hasConceptScore W3195217596C44249647 @default.
• W3195217596 hasConceptScore W3195217596C65409693 @default.
• W3195217596 hasConceptScore W3195217596C71924100 @default.
• W3195217596 hasConceptScore W3195217596C98274493 @default.

• next